General Information of Drug Therapeutic Target (DTT) (ID: TTVSFJW)

DTT Name Calcitonin gene-related peptide 1 (CALCA)
Synonyms Calcitonin gene-related peptide I; CGRP-I; CALCA; CALC1; Alpha-type CGRP
Gene Name CALCA
DTT Type
Clinical trial target
[1]
BioChemical Class
Cytotoxic amylin family
UniProt ID
CALCA_HUMAN
TTD ID
T93509
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Sequence
MGFQKFSPFLALSILVLLQAGSLHAAPFRSALESSPADPATLSEDEARLLLAALVQDYVQ
MKASELEQEQEREGSRIIAQKRACDTATCVTHRLAGLLSRSGGVVKNNFVPTNVGSKAFG
RRRRDLQA
Function
CGRP induces vasodilation. It dilates a variety of vessels including the coronary, cerebral and systemic vasculature. Its abundance in the CNS also points toward a neurotransmitter or neuromodulator role. It also elevates platelet cAMP.
Reactome Pathway
Calcitonin-like ligand receptors (R-HSA-419812 )
G alpha (s) signalling events (R-HSA-418555 )

Molecular Interaction Atlas (MIA) of This DTT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DTT
1 Clinical Trial Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cizolirtine DMOFTRE Neuropathic pain 8E43.0 Phase 2 [1]
------------------------------------------------------------------------------------
12 Investigative Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ac-VTHRLAGLLSRSGGVVKNNFVPTDVGPFAF-NH2 DMO0W9V Discovery agent N.A. Investigative [2]
Ac-VTHRLAGLLSRSGGVVRKNFVPTDVGPFAF-NH2 DMWJ2M5 Discovery agent N.A. Investigative [2]
Ac-WVEHRLKGELSRKGGVV[hArg]KNFVPTDVGPFAF-NH2 DM9W21L Discovery agent N.A. Investigative [2]
Ac-WVTHQLAGLLSQSGGVVRKNFVPTDVGPFAF-NH2 DM3BUP6 Discovery agent N.A. Investigative [2]
Ac-WVTHRLAGLLSRSGGVVRKNFVPTDVGPFAF-NH2 DMSMVK4 Discovery agent N.A. Investigative [2]
Ac-WVTHRLAGLLS[Cit]SGGVVRKNFVPTDVGPFAF-NH2 DMKO982 Discovery agent N.A. Investigative [2]
Ac-WVTH[Cit]LAGLLSRSGGVVRKNFVPTDVGPFAF-NH2 DMR1N53 Discovery agent N.A. Investigative [2]
Ac-WVTH[Cit]LAGLLS[Cit]SGGVVRKNFVPTDVGPFAF-NH2 DMJU4AM Discovery agent N.A. Investigative [2]
Ac-WVTH[hArg]LAGLLS[hArg]SGGVVRKNFVPTDVGPFAF-NH2 DM19NMF Discovery agent N.A. Investigative [2]
FV-Aib-TDVGPFAF DMEI890 Discovery agent N.A. Investigative [2]
VTHRLAGLLSRSGGVVKNNFVPTNVGSKAF-NH2 DMJ2PG1 Discovery agent N.A. Investigative [2]
WVTHRLAGLLSRSGGVVKNNFVPTNVGSKAF-NH2 DMVZB8U Discovery agent N.A. Investigative [2]
------------------------------------------------------------------------------------
⏷ Show the Full List of 12 Investigative Drug(s)

Molecular Expression Atlas (MEA) of This DTT

Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This DTT
Disease Name ICD 11 Studied Tissue p-value Fold-Change Z-score
Asthma CA23 Nasal and bronchial airway 1.80E-07 -0.32 -0.62
------------------------------------------------------------------------------------

References

1 Emerging drugs in neuropathic pain. Expert Opin Emerg Drugs. 2007 Mar;12(1):113-26.
2 Identification of potent, selective, and metabolically stable peptide antagonists to the calcitonin gene-related peptide (CGRP) receptor. J Med Chem. 2008 Dec 25;51(24):7889-97.